- Home
- ORKA vs ADV Comparison
ORKA vs ADV Comparison
Compare ORKA & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- ADV
- Stock Information
- Founded
- ORKA 2004
- ADV 1987
- Country
- ORKA United States
- ADV United States
- Employees
- ORKA N/A
- ADV N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ADV Business Services
- Sector
- ORKA Health Care
- ADV Consumer Discretionary
- Exchange
- ORKA Nasdaq
- ADV Nasdaq
- Market Cap
- ORKA 354.2M
- ADV 428.1M
- IPO Year
- ORKA N/A
- ADV N/A
- Fundamental
- Price
- ORKA $14.21
- ADV $1.54
- Analyst Decision
- ORKA Strong Buy
- ADV Strong Buy
- Analyst Count
- ORKA 8
- ADV 1
- Target Price
- ORKA $39.71
- ADV $2.50
- AVG Volume (30 Days)
- ORKA 360.1K
- ADV 712.4K
- Earning Date
- ORKA 08-15-2025
- ADV 08-06-2025
- Dividend Yield
- ORKA N/A
- ADV N/A
- EPS Growth
- ORKA N/A
- ADV N/A
- EPS
- ORKA N/A
- ADV N/A
- Revenue
- ORKA N/A
- ADV $3,526,704,000.00
- Revenue This Year
- ORKA N/A
- ADV N/A
- Revenue Next Year
- ORKA N/A
- ADV N/A
- P/E Ratio
- ORKA N/A
- ADV N/A
- Revenue Growth
- ORKA N/A
- ADV N/A
- 52 Week Low
- ORKA $5.49
- ADV $1.04
- 52 Week High
- ORKA $52.32
- ADV $4.16
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- ADV 54.54
- Support Level
- ORKA N/A
- ADV $1.28
- Resistance Level
- ORKA N/A
- ADV $1.67
- Average True Range (ATR)
- ORKA 0.00
- ADV 0.12
- MACD
- ORKA 0.00
- ADV 0.01
- Stochastic Oscillator
- ORKA 0.00
- ADV 66.67
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.